Abstract
Drug addiction is a major public health issue worldwide. The persistence of drug craving coupled with the known recruitment of learning and memory centers in the brain has led investigators to hypothesize that the alterations in glutamatergic synaptic efficacy brought on by synaptic plasticity may play key roles in the addiction process. Here we review the present literature, examining the properties of synaptic plasticity within drug reward circuitry, and the effects that drugs of abuse have on these forms of plasticity. Interestingly, multiple forms of synaptic plasticity can be induced at glutamatergic synapses within the dorsal striatum, its ventral extension the nucleus accumbens, and the ventral tegmental area, and at least some of these forms of plasticity are regulated by behaviorally meaningful administration of cocaine and / or amphetamine. Thus, the present data suggest that regulation of synaptic plasticity in reward circuits is a tractable candidate mechanism underlying aspects of addict ion.
Keywords: synaptic plasticity, drug reward circuitry, excitatory synapses, long-term depression(ltd)
Current Molecular Medicine
Title: Synaptic Plasticity in Drug Reward Circuitry
Volume: 2 Issue: 7
Author(s): Danny G. Winder, Regula E. Egli, Nicole L. Schramm and Robert T. Matthews
Affiliation:
Keywords: synaptic plasticity, drug reward circuitry, excitatory synapses, long-term depression(ltd)
Abstract: Drug addiction is a major public health issue worldwide. The persistence of drug craving coupled with the known recruitment of learning and memory centers in the brain has led investigators to hypothesize that the alterations in glutamatergic synaptic efficacy brought on by synaptic plasticity may play key roles in the addiction process. Here we review the present literature, examining the properties of synaptic plasticity within drug reward circuitry, and the effects that drugs of abuse have on these forms of plasticity. Interestingly, multiple forms of synaptic plasticity can be induced at glutamatergic synapses within the dorsal striatum, its ventral extension the nucleus accumbens, and the ventral tegmental area, and at least some of these forms of plasticity are regulated by behaviorally meaningful administration of cocaine and / or amphetamine. Thus, the present data suggest that regulation of synaptic plasticity in reward circuits is a tractable candidate mechanism underlying aspects of addict ion.
Export Options
About this article
Cite this article as:
Winder G. Danny, Egli E. Regula, Schramm L. Nicole and Matthews T. Robert, Synaptic Plasticity in Drug Reward Circuitry, Current Molecular Medicine 2002; 2 (7) . https://dx.doi.org/10.2174/1566524023361961
DOI https://dx.doi.org/10.2174/1566524023361961 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
An Overview and Therapeutic Promise of Nutraceuticals Against
Sports-Related Brain Injury
Current Molecular Pharmacology Cannabinoid Hyperemesis Syndrome
Current Drug Abuse Reviews Editorial (Thematic Issue: The Changing Face of Metabolic Syndrome and its Components in the Light of Current Knowledge)
Current Vascular Pharmacology Preliminary Studies on Optimization of Anti-Parkinson Drug Loaded Lipid Nanoparticles Enriched Hydrogel Formulations for Management of Parkinson’s Disease
Current Nanomedicine New Trends of Deep Learning in Clinical Cardiology
Current Bioinformatics Effect of PSEN1 mutations on MAPT methylation in early-onset Alzheimer’s disease
Current Alzheimer Research Hallucinations Associated with Topiramate Therapy: A Case Report and Review of the Literature
Current Drug Safety Non-Analgesic Effects of Opioids: Opioid-induced Respiratory Depression
Current Pharmaceutical Design Pharmacophore-Based Discovery of New Human Dihydroorotate Dehydrogenase Inhibitor
Medicinal Chemistry Combined Ischemic Preconditioning and Resveratrol Improved Bloodbrain Barrier Breakdown <i>via</i> Hippo/YAP/TAZ Signaling Pathway
CNS & Neurological Disorders - Drug Targets Nasal Neuro EPO Could be a Reliable Choice for Neuroprotective Stroke Treatment
Central Nervous System Agents in Medicinal Chemistry Anti-Cancer Drugs of Today and Tomorrow: Are we Close to Making the Turn from Treating to Curing Cancer?
Current Pharmaceutical Design Motif Discovery in Speech: Application to Monitoring Alzheimer’s Disease
Current Alzheimer Research Delayed Treatment with Nicotinamide Inhibits Brain Energy Depletion,Improves Cerebral Microperfusion, Reduces Brain Infarct Volume, but does not Alter Neurobehavioral Outcome Following Permanent Focal Cerebral Ischemia in Sprague Dawley Rats
Current Neurovascular Research Substance Abuse, HIV-1 and Hepatitis
Current HIV Research C-Abl Inhibition; A Novel Therapeutic Target for Parkinson's Disease
CNS & Neurological Disorders - Drug Targets HspB1 Dynamic Phospho-Oligomeric Structure Dependent Interactome as Cancer Therapeutic Target
Current Molecular Medicine Therapeutic Potential of Host Defense Peptides in Antibiotic-resistant Infections
Current Pharmaceutical Design The Role of Malnutrition in Older Persons with Mobility Limitations
Current Pharmaceutical Design Prospects for Caspase Inhibitors
Mini-Reviews in Medicinal Chemistry